Summary: A short ischemic episode preceding sustained ischemia is known to increase tolerance against ischemic cell death, We report early-onset long-lasting neuroprotec tion against in vitro hypoxia by preceding selective chemi cal inhibition of oxidative phosphorylation: "chemical pre conditioning," The amplitude of CAl population spikes (psap) in hippocampal slices prepared from control animals (control slices) was 31 ± 27% (mean ± SD) upon 45-min recovery from 15-min in vitro hypoxia, In slices prepared from animals treated in vivo with 20 mg/kg 3-nitropropio nate (3-np) 1-24 h prior to slice preparation (precondi tioned slices), psap improved to 90 ± 15% (p < 0,01), Inhibition of oxidative energy metabolism has been suggested to increase glutamate receptor mediated neurotoxicity (Novelli et aI., 1988; Simp son and Isacson, 1993), which is believed to be of major importance in ischemic cell death (Rothman and Olney, 1986) . However, increased neuronal sus ceptibility to cell death after metabolic impairment may be contrasted by physiologically relevant adapta tions. Depending on the time pattern of metabolic perturbations, a short ischemic or hypoxic episode may increase or decrease tolerance toward subse quent severe ischemia in heart and brain (Murry et aI., 1986; Schurr et aI., 1986; Tomida et aI., 1987; Kato et aI., 1989 Kato et aI., , 1991 Kitagawa et aI., 1990; Lutz, 1992 Ab b rev iations used : CL, chemoluminescence; 3-np, 3-nitropropi onate; psap, amplitude of population spike; SDH, succinic dehy drogenase.
conditioning," The amplitude of CAl population spikes (psap) in hippocampal slices prepared from control animals (control slices) was 31 ± 27% (mean ± SD) upon 45-min recovery from 15-min in vitro hypoxia, In slices prepared from animals treated in vivo with 20 mg/kg 3-nitropropio nate (3-np) 1-24 h prior to slice preparation (precondi tioned slices), psap improved to 90 ± 15% (p < 0,01), Inhibition of oxidative energy metabolism has been suggested to increase glutamate receptor mediated neurotoxicity (Novelli et aI., 1988; Simp son and Isacson, 1993) , which is believed to be of major importance in ischemic cell death (Rothman and Olney, 1986) . However, increased neuronal sus ceptibility to cell death after metabolic impairment may be contrasted by physiologically relevant adapta tions. Depending on the time pattern of metabolic perturbations, a short ischemic or hypoxic episode may increase or decrease tolerance toward subse quent severe ischemia in heart and brain (Murry et aI., 1986; Schurr et aI., 1986; Tomida et aI., 1987; Kato et aI., 1989 Kato et aI., , 1991 Kitagawa et aI., 1990; Lutz, 1992) : ischemic preconditioning. The time pattern seems to Posthypoxic oxygen free radicals were reduced to 65 ± 10% (mean ± SD) of control in preconditioned slices (p < 0,05). Posthypoxic neuronal density improved from 52 ± 15% (mean ± SD) in control slices to 97 ± 23% in preconditioned slices (p < 0.001). Glibenclamide, an antagonist at KATP-channels, partly reversed increased hyp oxic tolerance. We conclude that chemical preconditioning induces early-onset long-lasting tolerance against in vitro hypoxia. Ultimately, this strategy may be applicable as a neuroprotective strategy in humans. Key Words: Hyp oxia-Chemical preconditioning-Neuroprotection Succinic dehydrogenase-Hippocampal slice.
be rather critical in heart as well as in brain. Ischemia during the time span used to induce early-onset toler ance in heart muscle causes an aggravation of mor phologic lesions in brain (Kato et aI., 1991; Li and Kloner, 1994) . On the contrary, the time window to induce tolerance against subsequent ischemia by a short preceding ischemic episode is limited to � 1 h in heart, while it may last a few days in brain (Kato et aI., 1991; Li and Kloner, 1994) . Several mechanisms have been proposed to mediate increased tolerance against prolonged hypoxia or ischemia. For neuronal tissue, long-lasting tolerance has been related to a change in activity of ATPases, e.g., a reduced activity of Na+/K+-ATPase and increased activity of Mg 2 +_ ATPase (Benzi et aI., 1993) . Likewise, changes in the activity of respiratory enzymes (Dagani et aI., 1984) and expression of heat shock proteins (Kirino et aI., 1991; Liu et aI., 1993) have been suggested. Early onset ischemic preconditioning in heart muscle has been related to activation of ATP-regulated potas sium channels (Gross and Auchampach, 1992) . Involvement of KATP-channels also has been shown in preconditioning of brain after short ischemic epi-sodes (Heurteaux et aI., 1995) and chemical hypoxia (Riepe et aI., 1996a) . 3-Nitropropionate (3-np) inhibits succinic dehy drogenase (SDH) activity by covalent binding (Coles et aI., 1979) . SDH activity and ATP levels decrease upon treatment with 3-np in mouse cortical explants (Ludolph et aI., 1992) and hippocampal slices (Riepe et aI., 1996a) . Application of 3-np in hippocampal slices has been shown to activate KATP-channels in CAl pyramidal cells (Riepe et aI., 1992) . Upon pro longed application, decrease of activity of Na+/K+ ATPase is observed (Riepe et aI., 1995) . While a strong age dependency of morphological lesions was observed (Brouillet et aI., 1993) , single dosage of up to 20 mg/kg in animals up to 400 g did not induce histological abnormalities in striatum. Application of 3-np therefore seemed a suitable strategy to chemi cally induce preconditioning with early onset and long duration.
Ischemic preconditioning already has been applied as a preventive cytoprotective strategy in the in situ human heart in coronary angioplasty (Tomai et aI., 1994) . Protection was reduced by glibenclamide (Tomai et aI., 1994) , an antagonist at the KATPchannel (Schmid-Antomarchi et aI., 1987). However, intermitt�nt occlusion of cerebral arteries in humans does not seem practicable. In contrast, development of a practical and safe pharmacological strategy to induce preconditioning might lead to a novel neuro protective treatment in diseases with increased risk for cerebral ischemia.
The goal of this study was to investigate whether increased tolerance against in vitro hypoxia can be induced by chemical inhibition of a selective step of oxidative phosphorylation.
MATERIALS AND METHODS

Preparation of slices
Hippocampal slices were prepared from control male Wi star rats (200-250 g) as described previously (Riepe et a!., 1992) . Prior to further treatment, slices were incubated for 2 h at 35°C in a static bath with Ringer solution contain ing NaCl 126 mM, KCl 5 mM, KHzP0 4 1.3 mM, MgS0 4 1.3 mM, CaCh 2.4 mM, NaHC03 26 mM, dextrose 10 mM, bubbled with 95% Oz and 5% COz. Similar slices were prepared from animals pretreated in vivo with a single intraperitoneal injection of 20 mg/kg wt 3-np as described previously (Riepe et al., 1996a 
Oxygen free radicals
Parasagittal slices were prepared as described. Succes sively, they were transferred to a chamber perfused with 37°C Ringer solution containing 10-4 M of the chemolu minescence (CL) enhancer lucigenin. Lucigenin (N,N' dimethyldiacridinium; Sigma Chemicals) emits blue-green light upon reaction with superoxide. The slice chamber was housed in a double dark box, and the photons emitted from the slice were counted using a Hamamatsu photon counting system (Dirnagl et al., 1995) . After loading of lucigenin ( � 30-60 min) and recording of a stable CL baseline, slices were made hypoxic for 15 min by switching to a perfusion medium with a P aOZ < 15 mM Hg but otherwise unchanged composition. CL was recorded continuously during hypoxia and 2 h of reoxygenation.
Fluorometric NADH measurement 
Statistics
Statistical testing was performed by analysis of variance and Tukey's protected t test. Statistical significance was accepted at p < 0.05.
RESULTS
Histology
Hippocampal slices were prepared from controls (control slices) and animals pretreated in vivo with 20 mg/kg 3-np f at 1-24 h prior to slice preparation (preconditioned slices). The time to onset of in vitro hypoxia was at least 2 h, at most 6 h after prepara tion of slices. With this treatment, morphology upon 15 min of hypoxia in vitro is preserved in region CAl ( Fig. 2A) . Compared with untreated control slices (n = 10), neuronal density after 15-min hypoxia (n = 10) decreased to 52 :::': : 15% (mean:::,: : SD; p < 0.001 vs. untreated control slices). In preconditioned slices (n = 10), neuronal density after 15-min hypoxia was maintained at 97 :::': : 23% (p < 0.001 vs. hypoxia alone, no significant difference from controls) (Fig. 2B) .
Population spikes upon in vitro anoxia
The psap in hippocampal region CAl upon 15-min hypoxia in vitro was preserved better in precondi tioned slices (Fig. 3A) . A detailed time course of psap is shown in Fig. 3B . Ten minutes into hypoxia, the amplitude of the population spike already had decreased to 14:::': : 7% (mean:::': : SD; n = 9) in control slices, while it was 14:::': : 7% (n = 5) in preconditioned slices (time interval between in vivo treatment and slice preparation: 1 h). At the end of hypoxia (at 15 min), psap was 11 :::': : 4% in control slices vs. 14 :::': : 7% in preconditioned slices. After 15 min of re covery, psap was 37 :::': : 31% in control slices and 91 :::': : 20% in preconditioned slices. A similar differ ence of psap was observed after 45 min of recovery (31 :::': : 27% in control slices vs. 90 :::': : 15% in precon ditioned slices). With a time interval of 24 h between in vivo pretreatment, psap 10 min into hypoxia was 18 :::': : 16% (n = 5). At the end of hypoxia, psap was 14 :::': : 12%. After 15 min of recovery, psap was 62 :::': : 28%, and after 45 min it was 107 :::': : 16%.
Oxygen free radicals upon in vitro anoxia
One possible toxic mechanism associated with postischemic tissue damage is increase of production of oxygen free radicals (Siesjo and Smith, 1991) . Lucigenin-enhanced CL, an indicator of oxygen free radical production, was reduced in preconditioned slices during the initial 60 min of reoxygenation after 15 min of hypoxia to 65 :::': : 10% (mean:::,: : SD; n = 5) of control slices (p < 0.05) (Fig. 3C and D) .
Antagonism to preconditioning by glibenclamide
When the preconditioned slices were perfused with Ringer solution containing 5 p.,M glibenclamide 10 min prior to onset of hypoxia, no change in psap was observed. psap amounted to 9 :::': : 5% (mean :::': : SE; n = 7) at the end of hypoxia. Recovery was delayed. psap was 54 :::': : 31 % after 15 min of recovery (p < 0.05 vs. preconditioned slices without additional treatment with glibenclamide) and 77 :::': : 25% after 45 min of posthypoxic recovery (Fig. 3B) . Similarly, reversal of the decrease in posthypoxic oxygen free radical production was observed (104 :::': : 14%, mean :::': : SD, NS from control, p < 0.05 vs. preconditioning alone; n = 5). A similar trend was observed for the protective effect on morphologic lesions. However, while neuronal density was lower in preconditioned slices treated additionally with glibenclamide (88 :::': : 18%, mean:::': : SD; n = 10), this result did not reach levels of significance. A TP content of preconditioned slices upon hypoxia was not different with and with out additional treatment with glibenclamide (data not shown).
Preconditioning against selective chemical inhibition of mitochondrial complex IV
Preconditioning following in vivo administration of 3-np could also be shown to protect against subse quent severe chemical hypoxia by cyanide in vitro. By fluorometric measurement of NADH (Riepe et aI., 1996b) , a preconditioning effect on energy me tabolism could be observed in both hippocampal region CAl and hippocampal region CA3 (Fig. 4) . After 10 min of perfusion with 1 mM cyanide in vitro, NADH fluorescence increased to 111 :::': : 9% (mean:::,: : SD; n = 10) in hippocampal region CAJ of preconditioned slices and to 127 :::': : 23% in control slices (p < 0.05; n = 10). In hippocampal region CAL, an increase to 123 :::': : 17% in control slices and to , slices subjected to hypoxia without pretreatment (middle; note dark shrunken nucleus in necrotic neurons), and slices from animals pretreated in vivo with 20 mg/kg 3-nitropropionate 3 h prior to in vitro hypoxia (right). Vacuoles in controls may be linked to slicing procedure (Feig and Lipton, 1990) . original magnification X3,540. B: Mean neuronal density of CA, hippocampal region (arbitrary units). X: p < 0.001; hypoxia-preconditioned and hypoxia: p < 0.001; control-preconditioned and hypoxia not significant; analysis of variance and Tukey test.
108 :±: 6% in preconditioned slices was observed (p < 0.05). In control slices, NADH fluorescence after 10 min of 1 mM cyanide was already maximal, while in preconditioned slices the maximum was reached not before 20 min of continued application of cyanide. At this time, the fluorescence was 120 :±: 13% in CAl and 114 :±: 6% in CAJ.
DISCUSSION
A short ischemic or hypoxic episode is known to increase tolerance toward subsequent severe isch-
emia in heart and brain (Murry et al., 1986; Kita gawa et al., 1990) . However, intermittent occlusion of cerebral arteries is an unlikely perspective for a practical neuroprotective strategy in humans. This study shows that a single intraperitoneal injection of a selective inhibitor of SDH (mitochondrial com plex II) increases tolerance against subsequent hyp oxia. Increased tolerance can be shown functionally and histologically. Similar to previous observations at an even higher dosage (Simpson and Isacson, 1993) , the treatment itself does not impair pathologi cal or gross clinical parameters in vivo. In analogy to ischemic preconditioning, we suggest the term "chemical preconditioning" for the induction of tolerance to massive disruption of energy metabo lism by preceding inhibition of oxidative phosphory lation. With this paradigm, a protective effect of early onset and long duration can be shown. Pre viously, it was demonstrated by Heurteux et a1.
(1995) that preconditioning ischemia protects against lethal ischemia when applied with a time interval of 3 days, but worsens the damage when applied with a time interval of 1 h. Additionally, it was shown that pharmacologic induction of pre conditioning with agonists at adenosine receptors, activating KATP-channels, has a protective effect when applied with a time interval of 15-30 min preceding lethal ischemia (Heurteaux et aI., 1995 (A) vating KATP-channels. This is in good harmony with the observation that KATP-channels are activated upon application of 3-np (Riepe et aI., 1992 (Riepe et aI., , 1996a . Increased tolerance by chemical preconditioning therefore has an early onset and is long-lasting. Chemical preconditioning by selective inhibition of mitochondrial complex II does not act only by a change in succinate-related oxidation. As is shown by a delayed increase of NADH upon application of cyanide, chemical preconditioning also influences NADH-related oxidation [as expected, NADH does not increase upon prolonged application of 3-np in hippocampal slices (Riepe et aI., 1996b ) ]. This could indicate facilitated adaptation to increased demand (8) on preservation of energy production during disrup tion of oxidative metabolism in general. Alterna tively, this could indicate decreased demand for maintenance of energy-requiring processes, in partic ular for restoration of ionic homeostasis upon synap tic activity. One mechanism that may participate in the latter is hyperpolarization due to activation of KATP-channels. The mechanism by which antagonists at KATP-channels interfere with preconditioning could be an accelerated neuronal depolarization upon inhibition of oxidative phosphorylation (Riepe et aI., 1992) . Indeed, it has been suggested previously that KATP-channels are involved in induction of chemical (Riepe et aI., 1996a) and ischemic (Heur teaux et aI., 1995) preconditioning in brain. However, incomplete reversal of increased tolerance by gliben clamide, an antagonist at KATP-channels, indicates that other mechanisms are involved in addition. Fur ther, the present study gives additional evidence that protection against neuronal damage upon hypoxia is associated with a reduction of posthypoxic free oxy gen radicals. This reduction in posthypoxic free oxy gen radicals is reversed by additional treatment of slices with glibenclamide prior to hypoxia.
Further understanding of the mechanism(s) in volved in chemical preconditioning is of great interest not only for development of a neuroprotective strat egy, but also for understanding of the pathophysio logic cascade of excitatory agents in ischemic/hypoxic cell death. While aggravation of morphological dam age is observed upon direct application of excitants after systemic pretreatment with 3-np (Simpson and Isacson, 1993) , we demonstrated that neuronal death upon ischemia is reduced after chemical precondi tioning. Possibly this again indicates that neurotoxic ity of endogenous excitatory agents is not potentiated in situations of severely inhibited energy metabolism the more gradual or prolonged the onset of metabolic impairment is (Riepe et aI., 1995) . However, excitants may become toxic when the recovery mechanisms are impaired or overly stressed, e.g., by continuous or repeated application at short intervals of mito chondrial inhibitors (Brouillet et aI., 1993) or re peated ischemic episodes without sufficient time in between (Kato et aI., 1991) . A detailed understanding of beneficial and adverse conditions is necessary since several drugs widely applied in clinical practice in terfere with mitochondrial function and energy metabolism. Last, clinical applicability of ischemic preconditioning has been demonstrated in coronary angioplasty (Tomai et aI., 1994) . While ischemic pre conditioning by ligation of cerebral arteries supplying the brain is not possible for practical reasons, in vivo chemical preconditioning is practicable experimen tally in animals and might also be in humans. Due to its early onset and long duration, chemical precon ditioning might provide an opportunity for a new neuroprotective strategy in high-risk situations for ischemic stroke. In analogy to ischemic precondition ing (Chen et aI., 1994) , it also might be inducible repeatedly. It might even be speculated that chemical preconditioning unknowingly is in use already, since some pharmaceuticals with widespread therapeutic applications are inhibitors of mitochondrial energy metabolism.
We conclude that chemical preconditioning is a novel and practical strategy of neuroprotection against othe(wise fatal inhibition of energy metabo lism with early onset and long duration. Chemical preconditioning reduces posthypoxic oxygen free radicals. Activation of KATP-channels participates in mediating the protective effect by mechanisms other than interference with intracellular ATP content. Ul timately, chemical preconditioning may be a novel useful neuroprotective strategy in diseases with lll creased risk for cerebral ischemia.
